[ Price : $8.95]
Harvard researchers say biosimilars are often approved by FDA before they are approved in Europe.[ Price : $8.95]
FDA approves BlueWillow Biologics to conduct a Phase 1 study of its next-generation intranasal anthrax vaccine candidate BW-1010.[ Price : $8.95]
FDA announces a 12/5 public meeting on its Standard Core Clinical Outcome Assessments and Endpoints Pilot Grant Program.[ Price : $8.95]
Researchers argue for expanded FDA regulation of health apps to prevent harm to consumers.[ Price : $8.95]
FDA grants Moderna a fast track designation for mRNA-3927, its investigational mRNA therapeutic for propionic acidemia.[ Price : $8.95]
The National Council on Disability says FDA and other federal agencies should have active oversight over prenatal genetic testing.[ Price : $8.95]
Provention Bio says its Phase 2 PRINCE clinical trial evaluating twice-daily Crohns disease drug PRV-6527 showed that the therapy ...[ Price : $8.95]
FDA releases the FDA-483 with three observations from an inspection at East Marietta Drug Company.